What Changed at Anupam Rasayan: A ₹1,369 Cr Pharma Deal.
A deal both companies brushed off as “speculation” in February is now signed — and Bliss GVS shareholders have a number to weigh. Anupam…
STOCK MARKET NEWS THAT MOVES YOU
A deal both companies brushed off as “speculation” in February is now signed — and Bliss GVS shareholders have a number to weigh. Anupam…